Abstract: Disclosed herein is an auto injector for administering a medicament, the auto injector comprising: a housing; a cartridge receiver configured to receive a cartridge comprising a first stopper and a cartridge compartment containing the medicament, the cartridge compartment having a first cartridge subcompartment containing a first medicament component of the medicament and a second cartridge subcompartment containing a second medicament component of the medicament; a drive module coupled to move a plunger rod between a retracted plunger rod position and an extended plunger rod position, the plunger rod being configured to move the first stopper; a processing unit coupled to the drive module, wherein the processing unit is configured to control the drive module to move the plunger rod from a first plunger rod position to a mix plunger rod position with a mix plunger rod speed, wherein the mix plunger rod position is selected to position the first stopper in a position wherein the first medicament component is m

Abstract: Disclosed herein is an auto injector for administering a medicament, the auto injector comprising: a housing; a cartridge receiver configured to receive a cartridge comprising a first stopper and a cartridge compartment containing the medicament, the cartridge compartment having a first cartridge subcompartment containing a first medicament component of the medicament and a second cartridge subcompartment containing a second medicament component of the medicament; a drive module coupled to move a plunger rod between a retracted plunger rod position and an extended plunger rod position, the plunger rod being configured to move the first stopper; a processing unit coupled to the drive module, wherein the processing unit is configured to control the drive module to move the plunger rod from a first plunger rod position to a mix plunger rod position with a mix plunger rod speed, wherein the mix plunger rod position is selected to position the first stopper in a position wherein the first medicament component is m

Abstract: A measuring device for acquiring a three-dimensional measuring point related to a target in a scene, the measuring device comprises a base unit, a support unit mounted on the base unit, a distance measuring unit comprising an emitting unit configured for emitting measuring radiation and a receiving unit configured for detecting at least a part of the measuring radiation reflected by the target and a directing unit mounted in the support unit configured for directing the measuring radiation towards the scene. The measuring device comprises a capturing unit, wherein the capturing unit is configured for capturing at least a scene image of at least part of the scene, the scene image is generated by the detection of visual-spectrum light, and a controlling and processing unit, wherein the controlling and processing unit is configured for aligning the directing unit.

Abstract: A measuring device for acquiring a three-dimensional measuring point related to a target in a scene, the measuring device comprises a distance measuring unit comprising an emitting unit configured for emitting collimated measuring radiation (T) and a receiving unit configured for detecting at least a part of the collimated measuring radiation reflected (R) by the target, a directing unit rotatable around an elevation axis and configured for directing the measuring radiation towards the scene, a capturing unit, wherein the capturing unit comprises an image sensor and is configured to capture at least a scene image of at least part of the scene, and a controlling and processing unit configured at least for aligning the directing unit.

Abstract: Disclosed are methods of treating an aneurysm in a subject comprising administering to the subject a therapeutically effective amount of a composition comprising a SELP. Disclosed are methods of preventing rupture of an aneurysm comprising administering to a subject having an aneurysm a composition comprising a SELP, wherein the SELP is present in the aneurysm and prevents rupture. Also disclosed are methods of embolizing an aneurysm in a subject comprising administering to the subject a therapeutically effective amount of a composition comprising SEEP. Disclosed are methods of treating AVM in a subject comprising administering to the subject a composition comprising a SELP. In some aspects, the SELP embolizes an abnormal blood vessel in the AVM. Disclosed are methods of embolizing an AVM in a subject comprising administering to the subject a therapeutically effective amount of a composition comprising a SELP, wherein the SELP embolizes an abnormal blood vessel in the AVM.

Abstract: Described herein are in situ gelling compositions. The compositions include an anti-inflammatory polysaccharide and a gelling polymer, wherein the composition is a liquid prior to administration to a subject but converts to a gel upon administration to the subject. The compositions described herein have numerous applications with respect to the local treatment (reduction or prevention) of inflammation and/or tissue damage.

Abstract: A measurement system is provided for a wind turbine having a plurality of rotor blades mounted to a spinner at the front of a nacelle and arranged to rotate in a rotor plane. The measurement system includes a measuring device for determining a pressure at a number of pressure measurement points. The pressure measurement points are arranged in front of the rotor plane, an analysis module for generating a control signal on the basis of the pressure measurements, and output means for issuing the control signal to a controller of the wind turbine.

Abstract: A nucleic acid probe, a method of immobilizing the nucleic acid probe to a solid support and the solid support including the immobilized probes using UV light. The nucleic acid probe includes a terminus anchor chain portion, and a capture portion wherein the terminus anchor chain portion includes a sequence of at least 18 nucleotides composed of stretches of up to 5 nucleotides of base type X with intermediate nucleotide(s) of base type Cytosine (C) and optionally one nucleotide of base type Guanine (G) or a sequence with at least 90% similarity thereto, wherein each base type X independently of each other designate base type Thymine (T) or base type Uracil (U).

Abstract: Described herein are chemoembolic compositions and agents. The compositions include one or more anti-cancer agents and a silk-elastinlike protein polymer, wherein the compositions are liquids prior to administration to a subject but convert to hydrogels upon administration to the subject. Administration of the Chemoembolic compositions to tumor and/or tumor vasculature in a subject having cancer can result in reduced or inhibited blood flow to the tumor as well as localized, sustained release of the anti-cancer agent in the vicinity of the tumor. Reduction in blood flow, in turn, results in a reduction of tumor volume and/or inhibition of tumor growth, while localized release of the anti-cancer agent results in reduced systemic effects and lower overall toxicity of treatment with the compositions.

Abstract: Described herein are chemoembolic compositions and agents. The compositions include one or more anti-cancer agents and a silk-elastinlike protein polymer, wherein the compositions are liquids prior to administration to a subject but convert to hydrogels upon administration to the subject. Administration of the chemoembolic compositions to tumor and/or tumor vasculature in a subject having cancer can result in reduced or inhibited blood flow to the tumor as well as localized, sustained release of the anti-cancer agent in the vicinity of the tumor. Reduction in blood flow, in turn, results in a reduction of tumor volume and/or inhibition of tumor growth, while localized release of the anti-cancer agent results in reduced systemic effects and lower overall toxicity of treatment with the compositions.

Abstract: In the present invention a family of preferably bio-based resins is disclosed. The resins exhibit a broad range of applicability in terms of suitable processing techniques. The resins are designed in a manner that allows the introduction of functional in the resin backbone capable of providing adhesion towards reinforcements. The invention also relates to specimen manufactured with said resin.

Abstract: Described herein are in situ gelling compositions. The compositions include an anti-inflammatory polysaccharide and a gelling polymer, wherein the composition is a liquid prior to administration to a subject but converts to a gel upon administration to the subject. The compositions described herein have numerous applications with respect to the local treatment (reduction or prevention) of inflammation and/or tissue damage.

Abstract: A device for absorbing heat generated by curing of a curable matrix material, particularly heat generated by curing of a curable matrix material embedding a textile structure including a number of reinforcing fibers is provided. The device includes at least one envelope element defining at least one inner volume, and at least one thermally conductive heat absorbing element disposed within the at least one inner volume of the at least one envelope element. In a further embodiment, the at least one envelope element may be built of or include at least one non-adhering material which does not adhere to the curable or cured matrix material.

Abstract: A nucleic acid probe, a method of immobilizing the nucleic acid probe to a solid support and the solid support including the immobilized probes using UV light. The nucleic acid probe includes a terminus anchor chain portion, and a capture portion wherein the terminus anchor chain portion includes a sequence of at least 18 nucleotides composed of stretches of up to 5 nucleotides of base type X with intermediate nucleotide(s) of base type Cytosine (C) and optionally one nucleotide of base type Guanine (G) or a sequence with at least 90% similarity thereto, wherein each base type X independently of each other designate base type Thymine (T) or base type Uracil (U).

Abstract: Described herein are chemoembolic compositions and agents. The compositions include one or more anti-cancer agents and a silk-elastinlike protein polymer, wherein the compositions are liquids prior to administration to a subject but convert to hydrogels upon administration to the subject. Administration of the chemoembolic compositions to tumor and/or tumor vasculature in a subject having cancer can result in reduced or inhibited blood flow to the tumor as well as localized, sustained release of the anti-cancer agent in the vicinity of the tumor. Reduction in blood flow, in turn, results in a reduction of tumor volume and/or inhibition of tumor growth, while localized release of the anti-cancer agent results in reduced systemic effects and lower overall toxicity of treatment with the compositions.

Abstract: A method of determining a degree of yaw error of a wind turbine is provided. The method includes obtaining wind pressure measurement values from in front of the rotor plane, which wind pressure measurement values exhibit a periodic nature related to a rotation of a spinner of the wind turbine, performing a signal processing step to process the wind pressure measurement values to determine a phase offset of the wind pressure measurement values relative to an angular reference, and deriving a yaw error angle from the phase offset. A method of establishing a relationship between a phase offset of wind pressure measurement values and a degree of yaw error of a wind turbine, a yaw error determination unit, and a wind turbine are also provided.

Abstract: A casting apparatus is provided. The apparatus comprises a resin overflow container for use in casting processes, comprising: a curing accelerator for a resin in the overflow container. The resin overflow container may include a compartment arranged within the overflow container. The compartment may be adapted to release the curing accelerator after the overflow container has been at least partly filled with resin. The apparatus may also include a mold; and a drain connecting the mold and the overflow container or being part of an overflow container outlet for drawing off resin of the overflow container.

Abstract: In a content providing system, in a case where the display of an advertisement is instructed during the playback of content data, a client device pauses the playback of content data and plays back the advertisement data. A content providing device, after the advertisement data is played, increases the amount of time for which the content data can be played by an amount predefined for the advertisement Also, the content providing device, after transmitting the advertisement data, transmits content data corresponding to the amount of time for which content data can be played.

Abstract: A method for modifying a rate of temperature change of an epoxy resin composition in a resin container during a resin casting process is proposed. The resin composition has at least one epoxy monomer component and a curing agent. A passivation agent for the curing agent is added to the epoxy resin composition. A resin container arrangement for use in such a resin transfer moulding process, a composite product having an epoxy resin composition, and a use of an organic acid in an epoxy resin casting process as a passivation agent for modifying the rate of temperature change in a resin container containing an epoxy resin composition are proposed.

Abstract: A method for modifying a rate of temperature change of an epoxy resin composition in a resin container during a resin casting process is proposed. The resin composition has at least one epoxy monomer component and a curing agent. A passivation agent for the curing agent is added to the epoxy resin composition. A resin container arrangement for use in such a resin transfer moulding process, a composite product having an epoxy resin composition, and a use of an organic acid in an epoxy resin casting process as a passivation agent for modifying the rate of temperature change in a resin container containing an epoxy resin composition are proposed.